Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Homo sapiens

ABSTRACT: Dysregulation of the epigenetic landscape of normal aging in Alzheimer's disease [ChIP-Seq]

PROVIDER: PRJNA330668 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
	SRR6145540.fastq.gz	Fastqsanger.gz
	SRR6145550.fastq.gz	Fastqsanger.gz
	SRR6145560.fastq.gz	Fastqsanger.gz
	SRR6145570.fastq.gz	Fastqsanger.gz
	SRR6145580.fastq.gz	Fastqsanger.gz

Items per page:

1 - 5 of 62

Similar Datasets

Dysregulation of the epigenetic landscape of normal aging in Alzheimer's disease

Project description:Dysregulation of the epigenetic landscape of normal aging in Alzheimer's disease

| PRJNA413544 | ENA

Dysregulation of the epigenetic landscape of normal aging in Alzheimer's disease [RNA-Seq]

Project description:Dysregulation of the epigenetic landscape of normal aging in Alzheimer's disease [RNA-Seq]

| PRJNA413568 | ENA

An integrated multi-omics approach identifies epigenetic alterations associated with Alzheimer’s disease (H3K9ac, H3K27ac, H3K122ac, H3K4me1) [ChIP-Seq]

Project description:We report the epigenetic landscape of multiple histone marks in human hippocampus subject to normal aging and Alzheimer's disease.

2020-01-01 | GSE130746 | GEO

An integrated multi-omics approach identifies epigenetic alterations associated with Alzheimer’s disease (RNA-seq) [RNA-seq]

Project description:We report the bulk RNA-seq in human hippocampus subject to normal aging and Alzheimer's disease.

2020-10-21 | GSE159699 | GEO

An integrated multi-omics approach identifies epigenetic alterations associated with Alzheimer’s disease (RNA-seq with ERCC spike-in) [RNA-Seq]

Project description:We report the ERCC spike-in controlled RNA-seq in human hippocampus subject to normal aging and Alzheimer's disease.

2020-07-07 | GSE153873 | GEO

The epigenomic landscape of cognitive stimulation in the context of aging in mouse dorsal hippocampus - SWATH

Project description:Aging is a universal biological phenomenon linked to many diseases, such as cancer or neurodegeneration. However, the molecular mechanisms underlying aging, or how lifestyle interventions such as cognitive stimulation can ameliorate this process, are yet to be clarified. Here, we performed a multi-omic profiling, including RNA-seq, ATAC-seq, ChIP-seq, EM-seq, SWATH-MS and single cell Multiome scRNA and scATAC-seq, in the dorsal hippocampus of young and old mouse subjects which were subject to cognitive stimulation using the paradigm of environmental enrichment. In this study we were able to describe the epigenomic landscape of aging and cognitive stimulation.

2023-09-29 | PXD045567 | Pride

An integrated multi-omics approach identifies epigenetic alterations associated with Alzheimer’s disease (5hmC) [5hmC-Seal]

Project description:We report the 5hmC in human hippocampus subject to normal aging and Alzheimer's disease.

2020-10-21 | GSE159671 | GEO

Ensheathing glia promote healthy brain aging

Project description:Drosophila ensheathing glia decline in relative numbers during normal aging. Using p35, we inhibit apoptosis specifically in ensheathing glia, and show that this is sufficient to rescue the decline in ensheathing glia, improve neuromotor performance of aged flies, and increase lifespan. Remaining ensheathing glia from aged brains exhibit transcriptomes exhibiting signs of lipid metabolism and apoptosis dysregulation. Expanding ensheathing glia with p35 also prevented the accumulation of amyloid plaques and delayed premature death in a fly model of Alzheimer's disease.

2023-02-20 | GSE179604 | GEO

Inhibition of EHMT1/2 rescues synaptic and cognitive functions for Alzheimer's disease

Project description:Epigenetic dysregulation, which leads to the alteration of gene expression in the brain, is suggested as one of the key pathophysiological bases of aging and neurodegeneration. Here we found that, in the late-stage familial Alzheimer’s disease (FAD) mouse model, repressive histone H3 dimethylation at lysine 9 (H3K9Me2) and euchromatic histone methyltransferases, EHMT1 and EHMT2 (H3K9Me2 catalyzer), were significantly elevated in the prefrontal cortex (PFC) region of post-mortem tissues from human patients with Alzheimer's disease. Concomitantly, H3K9Me2 at the promoter region of glutamate receptors was increased in PFC of aged FAD mice, which was linked to the diminished transcription, expression and function of AMPA and NMDA receptors. Treatment of FAD mice with specific EHMT1/2 inhibitors reversed histone hyper-methylation and led to the recovery of glutamate receptor expression and excitatory synaptic function in PFC and hippocampus. Chromatin immunoprecipitation-sequencing (ChIP-seq) data indicated that FAD mice exhibited genome-wide increase of H3K9Me2 enrichment at genes involved in neuronal signaling (including glutamate receptors), which was reversed by EHMT1/2 inhibition. Moreover, the impaired recognition memory, working memory, and spatial memory in aged FAD mice were rescued by the treatment with EHMT1/2 inhibitors. These results suggest that disrupted epigenetic regulation of glutamate receptor transcription underlies the synaptic and cognitive deficits in Alzheimer's disease, and targeting histone methylation enzymes may represent a novel therapeutic strategy for this prevalent neurodegenerative disorder.

2019-01-30 | GSE125850 | GEO

Homo sapiens

Project description:5-Hydroxymenthylation-associated Epigenetic Modifiers in Alzheimer's disease

| PRJNA295049 | ENA